価格表

在庫・価格 : 2025年07月17日 13時35分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-TROP-2, Human, Goat-Poly
データシート※最新のデータシートでない場合があります
AF650 RSDアールアンドディー システムズ
R&D Systems, Inc.
100 μg ¥83,000 1個 追加

在庫・価格 : 2025年07月17日 13時35分 現在

Anti-TROP-2, Human, Goat-Poly

  • 商品コード:AF650
  • メーカー:RSD
  • 包装:100μg
  • 価格: ¥83,000
  • 在庫:1個
使用文献
No. 文献情報 備考 参照
1 Ohmachi T et al. Clinical significance of TROP2 expression in colorectal cancer. Clin. Cancer Res. 2006 May;12(10):3057-63
Ohmachi T et al
2006/01/01
Application: IHC Paraffin-embedded, Sample Type: Whole Tissue PubMed
2 Wang J et al. Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers. Mol. Cancer Ther. 2008 Feb;7(2):280-5
Wang J et al
2008/01/01
Species: Mouse, Application: Migration Assay, Whole Cells PubMed
3 Nakatsukasa M et al. Tumor-associated calcium signal transducer 2 is required for the proper subcellular localization of claudin 1 and 7: implications in the pathogenesis of gelatinous drop-like corneal dystrophy. Am. J. Pathol. 2010 Sep;177(3):1344-55
Nakatsukasa M et al
2010/01/01
Application: IHC Paraffin-embedded,Immunoprecipitation, Sample Type: Cell Lysates,Whole Tissue PubMed
4 Raji R et al. Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody. J. Exp. Clin. Cancer Res. 2011;30:106
Raji R et al
2011/01/01
Application: IHC Paraffin-embedded, Sample Type: Whole Tissue PubMed
5 Eisenwort G et al. Identification of TROP2 (TACSTD2), an EpCAM-like molecule, as a specific marker for TGF-β1-dependent human epidermal Langerhans cells. J. Invest. Dermatol. 2011 Oct;131(10):2049-57
Eisenwort G et al
2011/01/01
Application: Flow Cytometry,ICC,IHC Frozen, Sample Type: Whole Cells,Whole Tissue PubMed
6 Trerotola M et al. Upregulation of Trop-2 quantitatively stimulates human cancer growth. Oncogene 2013 Jan;32(2):222-33
Trerotola M et al
2013/01/01
Application: ICC, Sample Type: whole cells PubMed
7 Ambrogi F et al. Trop-2 is a determinant of breast cancer survival. PLoS ONE 2014;9(5):e96993
Ambrogi F et al
2014/01/01
Application: Flow Cytometry,IHC Paraffin-embedded, Sample Type: Whole Cells,Whole Tissue PubMed
8 Xia Y et al. Expression of tumor-associated calcium signal transducer 2 in patients with salivary adenoid cystic carcinoma: Correlation with clinicopathological features and prognosis. Oncol Lett 2014 Oct;8(4):1670-1674
Xia Y et al
2014/01/01
Application: IHC Paraffin-embedded, Sample Type: Whole Tissue PubMed
9 Starodub AN et al. First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors. Clin. Cancer Res. 2015 Sep;21(17):3870-8
Starodub AN et al
2015/01/01
Application: IHC Not Specified, Sample Type: Whole Tissue PubMed
10 Vranic S et al. Potential Novel Therapy Targets in Neuroendocrine Carcinomas of the Breast. Clin. Breast Cancer 2019 Apr;19(2):131-136
Vranic S et al
2019/01/01
PubMed
11 Sin STK et al. TROP-2 exhibits tumor suppressive functions in cervical cancer by dual inhibition of IGF-1R and ALK signaling. Gynecol. Oncol. 2019 01;152(1):185-193
Sin STK et al
2019/01/01
PubMed
12 Zimmers SM et al. TROP2 methylation and expression in tamoxifen-resistant breast cancer. Cancer Cell Int. 2018;18:94
Zimmers SM et al
2018/01/01
PubMed
13 Guan H et al. Trop2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways. BMC Cancer 2017 Jul;17(1):486
Guan H et al
2017/01/01
PubMed
14 Han C et al. In vitro and in vivo activity of sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (Trop-2) in uterine serous carcinoma. Gynecol Oncol 2020 02;156(2):430-438
Han C et al
2020/01/01
PubMed
15 Kuai X et al. Trop2 Promotes Multidrug Resistance by Regulating Notch1 Signaling Pathway in Gastric Cancer Cells. Med Sci Monit 2020 Jan;26:e919566
Kuai X et al
2020/01/01
PubMed
16 Zeybek B et al. Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan. Sci Rep 2020 01;10(1):973
Zeybek B et al
2020/01/01
Species: Human, Applications: IHC PubMed
17 Hao Y et al. miR-488-3p sponged by circ-0000495 and mediated upregulation of TROP2 in head and neck squamous cell carcinoma development. J Cancer 2020;11(11):3375-3386
Hao Y et al
2020/01/01
Species: Human, Applications: IHC PubMed
  • No.: 1
  • 文献情報:
    Ohmachi T et al. Clinical significance of TROP2 expression in colorectal cancer. Clin. Cancer Res. 2006 May;12(10):3057-63
    Ohmachi T et al
    2006/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Wang J et al. Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers. Mol. Cancer Ther. 2008 Feb;7(2):280-5
    Wang J et al
    2008/01/01
  • 備考:
    Species: Mouse, Application: Migration Assay, Whole Cells
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Nakatsukasa M et al. Tumor-associated calcium signal transducer 2 is required for the proper subcellular localization of claudin 1 and 7: implications in the pathogenesis of gelatinous drop-like corneal dystrophy. Am. J. Pathol. 2010 Sep;177(3):1344-55
    Nakatsukasa M et al
    2010/01/01
  • 備考:
    Application: IHC Paraffin-embedded,Immunoprecipitation, Sample Type: Cell Lysates,Whole Tissue
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Raji R et al. Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody. J. Exp. Clin. Cancer Res. 2011;30:106
    Raji R et al
    2011/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Eisenwort G et al. Identification of TROP2 (TACSTD2), an EpCAM-like molecule, as a specific marker for TGF-β1-dependent human epidermal Langerhans cells. J. Invest. Dermatol. 2011 Oct;131(10):2049-57
    Eisenwort G et al
    2011/01/01
  • 備考:
    Application: Flow Cytometry,ICC,IHC Frozen, Sample Type: Whole Cells,Whole Tissue
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Trerotola M et al. Upregulation of Trop-2 quantitatively stimulates human cancer growth. Oncogene 2013 Jan;32(2):222-33
    Trerotola M et al
    2013/01/01
  • 備考:
    Application: ICC, Sample Type: whole cells
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Ambrogi F et al. Trop-2 is a determinant of breast cancer survival. PLoS ONE 2014;9(5):e96993
    Ambrogi F et al
    2014/01/01
  • 備考:
    Application: Flow Cytometry,IHC Paraffin-embedded, Sample Type: Whole Cells,Whole Tissue
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Xia Y et al. Expression of tumor-associated calcium signal transducer 2 in patients with salivary adenoid cystic carcinoma: Correlation with clinicopathological features and prognosis. Oncol Lett 2014 Oct;8(4):1670-1674
    Xia Y et al
    2014/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Starodub AN et al. First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors. Clin. Cancer Res. 2015 Sep;21(17):3870-8
    Starodub AN et al
    2015/01/01
  • 備考:
    Application: IHC Not Specified, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Vranic S et al. Potential Novel Therapy Targets in Neuroendocrine Carcinomas of the Breast. Clin. Breast Cancer 2019 Apr;19(2):131-136
    Vranic S et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Sin STK et al. TROP-2 exhibits tumor suppressive functions in cervical cancer by dual inhibition of IGF-1R and ALK signaling. Gynecol. Oncol. 2019 01;152(1):185-193
    Sin STK et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Zimmers SM et al. TROP2 methylation and expression in tamoxifen-resistant breast cancer. Cancer Cell Int. 2018;18:94
    Zimmers SM et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Guan H et al. Trop2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways. BMC Cancer 2017 Jul;17(1):486
    Guan H et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Han C et al. In vitro and in vivo activity of sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (Trop-2) in uterine serous carcinoma. Gynecol Oncol 2020 02;156(2):430-438
    Han C et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Kuai X et al. Trop2 Promotes Multidrug Resistance by Regulating Notch1 Signaling Pathway in Gastric Cancer Cells. Med Sci Monit 2020 Jan;26:e919566
    Kuai X et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Zeybek B et al. Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan. Sci Rep 2020 01;10(1):973
    Zeybek B et al
    2020/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Hao Y et al. miR-488-3p sponged by circ-0000495 and mediated upregulation of TROP2 in head and neck squamous cell carcinoma development. J Cancer 2020;11(11):3375-3386
    Hao Y et al
    2020/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed